VTRS vs Peers Stock Comparison

Viatris Prices as of Oct 26, 2026 Peers: Industry group
VTRS Viatris Inc
$18.29 +2.6% 1M +76.7% 1Y
Market cap
$21.01B
P/E
–
Revenue (TTM)
$14.74B
Div. yield
2.62%
Generic Drugs Healthcare

Percentile Scorecard

VTRS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisVTRS
Valuation 92 #22 of 275
Growth 49 #130 of 253
Profitability 82 #42 of 224
Financial Health 29 #211 of 296
Shareholder Returns 88 #16 of 126
Overall 68
  • VTRS ranked among 305 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodVTRSSPY
1 month +2.6% -0.8%
3 months +3.7% +3.5%
6 months +23.5% +7.0%
Year to date +46.9% +12.2%
1 year +76.7% +13.0%
3 years +108.6% +86.3%
3 years, per year +27.8% +23.1%
5 years +39.6% +68.6%
5 years, per year +6.9% +11.0%
10 years -52.0% +258.0%
10 years, per year -7.1% +13.6%

Risk

MeasureVTRSSPY
Volatility, 1Y 32.4% 12.7%
Downside volatility, 1Y 29.6% 12.7%
Beta vs S&P 500, 1Y 0.70 1.00
Return / volatility, 1Y 2.37 1.02
Max drawdown, 5Y -52.9% -25.4%
From 52-week high -2.0% -1.8%
52-week high $18.66 $779.14
52-week low $10.11 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleVTRS
P/E now vs peer median -51.8xmedian 10.4x
P/S now vs peer median 1.4xmedian 6.4x
EV/EBITDA now vs peer median 12.3xmedian 10.7x
P/FCF now vs peer median 10.7xmedian 12.5x
P/B now vs peer median 1.5xmedian 1.6x
PEG now vs peer median 1.69median 0.29

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsVTRS
Revenue $14.74B
Gross profit $5.13B
Operating income -$87.30M
Net income -$410.70M
Free cash flow $1.95B
R&D $1.02B
EPS (diluted) $-0.35
Cash & equivalents $886.50M
Total debt $13.35B
Shares (diluted) 1.16B
Enterprise value $16.02B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricVTRS
P/E -51.8x
P/FCF 10.7x
P/Operating cash flow 9.0x
P/S 1.4x
P/B 1.5x
P/Tangible book 36.0x
EV/EBITDA 12.3x
EV/EBIT -383.4x
EV/Revenue 2.3x
EV/FCF 17.1x
EV/Operating cash flow 14.4x
PEG (3Y EPS CAGR) 1.69

Growth

14 metrics
MetricVTRS
Revenue growth (1Y) 4.4%
Revenue CAGR (3Y) -1.9%
Gross profit growth (1Y) -0.7%
Gross profit CAGR (3Y) -6.0%
Operating income growth (1Y) 96.6%
Operating income CAGR (3Y) -27.6%
Net income growth (1Y) 88.2%
Net income CAGR (3Y) -30.5%
EPS growth (1Y) 88.1%
EPS CAGR (3Y) -30.6%
Operating cash flow growth (1Y) 12.9%
Operating cash flow CAGR (3Y) -3.0%
Free cash flow growth (1Y) 11.6%
Free cash flow CAGR (3Y) -3.6%

Profitability

14 metrics
MetricVTRS
Gross margin 34.8%
EBITDA margin 18.4%
Operating margin -0.6%
Pretax margin -4.5%
Net margin -2.8%
FCF margin 13.3%
Operating cash flow margin 15.8%
Return on equity -2.8%
Return on assets -1.1%
Return on invested capital -0.2%
Return on capital employed -0.3%
Asset turnover 0.4x
Cash conversion (OCF / net income) -5.7x
Stock comp / revenue 1.2%

Financial Health

11 metrics
MetricVTRS
Debt / assets 38.1%
Debt / equity 0.9x
Net debt / EBITDA 4.6x
Debt / FCF 6.8x
Liabilities / assets 59.3%
Equity / assets 40.7%
Interest coverage -0.2x
Current ratio 1.6x
Quick ratio 0.7x
Cash ratio 0.1x
Altman Z-score 1.13

Shareholder Returns

7 metrics
MetricVTRS
Dividend yield 2.6%
Net buyback yield 1.4%
Shareholder yield 4.1%
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusVTRS
Forward P/E 7.0xFY2026
EPS, next fiscal year $2.62FY2026
EPS growth, next FY +11.5%FY2026
EPS growth, the year after -1.9%
Revenue, next fiscal year $15.31BFY2026
Revenue growth, next FY +7.0%FY2026
Revenue growth, the year after -5.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersVTRS
Held by institutions 89.9%
Institutions holding 1,028
Change in shares held, QoQ +5.6%
Institutions buying 486
Institutions selling 318
Buyers to sellers 1.53

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which pays a higher dividend?

Only one of these companies pays a dividend: Viatris (VTRS) 2.62%.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.